UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014317
Receipt number R000016667
Scientific Title Effects of ingestion of a food on glycometabolism A randomized, double blind, placebo-controlled study
Date of disclosure of the study information 2014/06/19
Last modified on 2018/07/13 15:58:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of ingestion of a food on glycometabolism
A randomized, double blind, placebo-controlled study

Acronym

Effects of ingestion of a food on glycometabolism

Scientific Title

Effects of ingestion of a food on glycometabolism
A randomized, double blind, placebo-controlled study

Scientific Title:Acronym

Effects of ingestion of a food on glycometabolism

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to evaluate the effects of ingestion of a food on glycometabolism for japanese male and female between the ages of 20 years and 59 years.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

P1asma glucose, 2-hr PG, Insulin, TG, Glico albumin, Insulinogenic index, HOMA-IR

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingestion of food for 12 consecutive weeks

Interventions/Control_2

Ingestion of placebo for 12 consecutive weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

(1)Japanese male and female aged between 20 and 59 years

(2)Subjects who have blood sugar level between 140 and 199mg/dL at 120 minutes after 75g glucose load by OGTT and high levels of fasting blood sugar and triglyceride. The investigator judge whether subjects who have blood sugar level of between 200 and 210mg/dL are included in this study or not.

Key exclusion criteria

(1)Subjects who are treating diabetes or dyslipidemia

(2)Subjects who have a serious disease or health history

(3)Subjects who have disability of the functions of the heart and the lungs

(4)Subjects who were operated on the alimentary canal

(5)Subjects who are treating illness at present

(6)Subjects with food and medicine allergies

(7)Subjects who take vigorous exercise or are on a diet

Target sample size

44


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Makoto Terashima

Organization

Oneness Support Co., Ltd.

Division name

Clinical trial Division

Zip code


Address

Higashi-Tenma Building 8F, 1-7-17, Higashi Tenma, Kita-ku, Osaka

TEL

0648018917

Email

mterashima@oneness-sup.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Makoto Terashima

Organization

Oneness Support Co., Ltd.

Division name

Clinical trial Division

Zip code


Address

Higashi-Tenma Building 8F, 1-7-17, Higashi Tenma, Kita-ku, Osaka

TEL

0648018917

Homepage URL


Email

shiken@oneness-sup.co.jp


Sponsor or person

Institute

Oneness Support Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

FUJI OIL CO., LTD

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

みうらクリニック(大阪府)


Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 04 Month 24 Day

Date of IRB


Anticipated trial start date

2014 Year 06 Month 23 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 06 Month 19 Day

Last modified on

2018 Year 07 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016667


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name